Molecular determinants of prognosis in oesophageal cancer patients treated with chemoradiation

por Ajani, J A
Publicado 2008

High-dose cytosine arabinoside (Ara-C) in colorectal cancer.

por Kanojia, M., Kantarjian, H., Ajani, J., Barlogie, B.
Publicado 1983

In vitro cytotoxicity patterns of standard and investigational agents on human bone marrow granulocyte-macrophage progenitor cells.

por Ajani, J. A., Spitzer, G., Tomasovic, B., Drewinko, B., Hug, V. M., Dicke, K.
Publicado 1986

Tislelizumab versus chemotherapy as second-line treatment of advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302): impact on health-related quality of life

por Van Cutsem, E., Kato, K., Ajani, J., Shen, L., Xia, T., Ding, N., Zhan, L., Barnes, G., Kim, S.-B.
Publicado 2022

Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinoma

por Falk, S, Anthoney, A, Eatock, M, Van Cutsem, E, Chick, J, Glen, H, Valle, J W, Drolet, D W, Albert, D, Ferry, D, Ajani, J
Publicado 2006